Also trades as: 001060.KS (KSC) · $vol 1M · 001067.KS (KSC) · $vol 0M

₩22,600.00 ($16.82)

+600.00 (+2.73%)

Weekly Expected Move ±3.3%

₩21086 ₩21843 ₩22600 ₩23357 ₩24114

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · ₩398.7B mcap · 18M float · 0.0015% daily turnover

Analysis Technicals Weather Peers

Revenue

$774.8B +7.7% ▲

5Y CAGR: +7.2%

Gross Profit

$359.3B +11.1% ▲

5Y CAGR: +15.1%

Operating Income

$87.9B +6.5% ▲

Net Income

$61.7B -5.2% ▼

EPS (Diluted)

$2534.75 -4.1% ▼

EBITDA

$106.6B -3.2% ▼

5Y CAGR: +40.7%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$606.6B	$684.4B	$748.5B	$719.4B	$774.8B
YoY Growth	+10.8%	+12.8%	+9.4%	-3.9%	+7.7%
Cost of Revenue	$372.2B	$396.4B	$412.9B	$395.9B	$416.0B
Gross Profit	$234.4B	$288.0B	$335.7B	$323.5B	$359.3B
Gross Margin	38.6%	42.1%	44.8%	45.0%	46.4%
R&D Expenses	$19.9B	$33.7B	$33.7B	$36.2B	$0
SG&A Expenses	$115.3B	$126.7B	$152.6B	$157.9B	$167.1B
Operating Expenses	$203.2B	$225.2B	$235.2B	$241.0B	$271.4B
Operating Income	$31.2B	$63.0B	$100.3B	$82.5B	$87.9B
Operating Margin	5.1%	9.2%	13.4%	11.5%	11.3%
Interest Expense	$7.3B	$9.4B	$12.6B	$10.0B	$4.4B
Income Before Tax	$20.5B	$45.4B	$54.2B	$82.4B	$88.8B
Tax Expense	$22.0B	$15.5B	$16.4B	$17.4B	$27.3B
Net Income	-$919M	$31.9B	$37.0B	$65.0B	$61.7B
Net Margin	-0.2%	4.7%	4.9%	9.0%	8.0%
EPS (Diluted)	$-41.70	$1267.10	$1426.36	$2644.47	$2534.75
EBITDA	$45.1B	$73.5B	$89.2B	$110.2B	$106.6B
Shares Outstanding	23M	24M	25M	23M	24M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$178.7B	$187.9B	$185.2B	$191.1B	$200.0B	$198.4B	$199.9B	$222.0B
Cost of Revenue	$92.3B	$104.9B	$101.1B	$100.4B	$105.4B	$109.1B	$101.4B	$116.7B
Gross Profit	$86.4B	$83.0B	$84.2B	$90.7B	$94.6B	$89.8B	$98.5B	$105.3B
Gross Margin	48.3%	44.2%	45.4%	47.4%	47.3%	45.3%	49.3%	47.4%
R&D Expenses	$8.6B	$11.2B	$10.1B	$12.8B	$7.3B	$15.3B	$12.2B	$0
SG&A Expenses	$51.2B	$42.3B	$52.1B	$65.7B	$42.9B	$45.8B	$43.0B	$60.1B
Operating Expenses	$59.8B	$64.9B	$62.2B	$65.7B	$62.6B	$74.4B	$64.9B	$71.9B
Operating Income	$26.5B	$18.1B	$22.0B	$25.0B	$32.0B	$15.5B	$33.6B	$33.3B
Operating Margin	14.9%	9.6%	11.9%	13.1%	16.0%	7.8%	16.8%	15.0%
Interest Expense	$2.3B	$2.4B	$1.2B	$1.8B	$1.6B	$2.6B	$1.8B	$1.7B
Income Before Tax	$26.5B	$18.6B	$22.9B	$20.6B	$27.9B	$17.5B	$35.2B	$34.8B
Tax Expense	$6.8B	$2.1B	$5.4B	$22.5B	-$2.7B	$2.2B	$7.7B	$6.9B
Net Income	$19.7B	$16.6B	$17.5B	-$1.9B	$30.6B	$15.3B	$27.5B	$27.9B
Net Margin	11.0%	8.8%	9.4%	-1.0%	15.3%	7.7%	13.7%	12.6%
EPS (Diluted)	$807.00	$675.23	$714.00	$-80.39	$1267.00	$634.14	$1137.70	$1154.00
EBITDA	$33.6B	$25.6B	$28.2B	$95.3B	$36.7B	$12.1B	$38.6B	$38.4B
Shares Outstanding	24M	23M	23M	23M	24M	24M	23M	24M

001065.KS KSC